The Patent Finder

Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis

Ellodi Pharmaceuticals, L.P.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application PCT/US2014/054203, filed Sep 5, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,471,071Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis
In force
 · High confidence
UsedRemaining
Ellodi Pharmaceuticals, L.P.In forceHigh confidence
US 11,166,961Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis
In force
 · High confidence
Ellodi Pharmaceuticals, L.P.In forceHigh confidence
US 11,260,061Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis
In force
 · High confidence
Ellodi Pharmaceuticals, L.P.In forceHigh confidence
US 12,310,976Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis
In force
 · High confidence
Ellodi Pharmaceuticals, L.P.In forceHigh confidence
US 12,447,157Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis
In force
 · High confidence
Ellodi Pharmaceuticals, L.P.In forceHigh confidence
Application 19/179,530Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis
Pending
Not granted
Ellodi Pharmaceuticals, L.P.PendingNot granted
Application 19/403,674Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis
Pending
Not granted
Adare Development I, L.P.PendingNot granted
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Ellodi Pharmaceuticals, L.P..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited